Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Protéine HER2")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 51

  • Page / 3
Export

Selection :

  • and

Humoral immune responses in patients vaccinated with 1-146 HER2 protein complexed with cholesteryl pullulan nanogelKAGEYAMA, Shinichi; KITANO, Shigehisa; OLD, Lloyd J et al.Cancer science. 2008, Vol 99, Num 3, pp 601-607, issn 1347-9032, 7 p.Article

HER2-specific T-cell immune responses in patients vaccinated with truncated HER2 protein complexed with nanogels of cholesteryl pullulanKITANO, Shigehisa; KAGEYAMA, Shinichi; NISHIKAWA, Masakatsu et al.Clinical cancer research. 2006, Vol 12, Num 24, pp 7397-7405, issn 1078-0432, 9 p.Article

Étude du profil d'expression de la protéine HER2 dans 50 cas de cancers mammaires dans la wilaya d'Oran = Expression profile of the HER2 protein in 50 cases of breast cancer in the Wilaya of OranMEDJDOUB, A; TAHARI, Z; SAHRAOUI, T et al.Journal africain du cancer (Print). 2009, Vol 1, Num 3, pp 127-129, issn 1965-0817, 3 p.Article

Comparison of different approaches for assessment of HER2 expression on protein and mRNA level: prediction of chemotherapy response in the neoadjuvant GeparTrio trial (NCT00544765)NOSKE, A; LOIBL, S; HOFFMANN, G et al.Breast cancer research and treatment. 2011, Vol 126, Num 1, pp 109-117, issn 0167-6806, 9 p.Article

Comparison of HER2 gene amplification assessed by fluorescence in situ hybridization and HER2 protein expression assessed by immunohistochemistry in gastric cancerYANO, Tomonori; DOI, Toshihiko; OHTSU, Atsushi et al.Oncology reports. 2006, Vol 15, Num 1, pp 65-71, issn 1021-335X, 7 p.Article

Analytical validation and interobserver reproducibility of EnzMet GenePro : A second-generation bright-field metallography assay for concomitant detection of HER2 gene status and protein expression in invasive carcinoma of the breastDOWNS-KELLY, Erinn; PETTAY, James; HAINFELD, James et al.The American journal of surgical pathology. 2005, Vol 29, Num 11, pp 1505-1511, issn 0147-5185, 7 p.Article

Gene amplification and protein expression of EGFR and HER2 by chromogenic in situ hybridisation and immunohistochemistry in atypical adenomatous hyperplasia and adenocarcinoma of the lungAWAYA, H; TAKESHIMA, Y; FURONAKA, O et al.Journal of clinical pathology. 2005, Vol 58, Num 10, pp 1076-1080, issn 0021-9746, 5 p.Article

Structure of the extracellular region of HER2 alone and in complex with the Herceptin FabCHO, Hyun-Soo; MASON, Karen; RAMYAR, Kasra X et al.Nature (London). 2003, Vol 421, Num 6924, pp 756-760, issn 0028-0836, 5 p.Article

Absence of HER2 overexpression in metastatic malignant melanomaINMAN, J. Lucas; KUTE, Tim; WHITE, Wain et al.Journal of surgical oncology. 2003, Vol 84, Num 2, pp 82-88, issn 0022-4790, 7 p.Article

HER2 Protein and Gene Variation between Primary and Metastatic Breast Cancer: Significance and Impact on Patient CareFABI, Alessandra; DI BENEDETTO, Anna; SPERDUTI, Isabella et al.Clinical cancer research (Print). 2011, Vol 17, Num 7, pp 2055-2064, issn 1078-0432, 10 p.Article

In situ quantification of HER2-protein tyrosine kinase 6 (PTK6) protein-protein complexes in paraffin sections from breast cancer tissuesAUBELE, M; SPEARS, M; SCHMITT, M et al.British journal of cancer. 2010, Vol 103, Num 5, pp 663-667, issn 0007-0920, 5 p.Article

European Society for Medical Oncology (ESMO) and the European Society for the Cancer Immunology and Immunotherapy (ESCII) International Symposium on ImmunologyCancer immunology and immunotherapy. 2008, Vol 57, Num 10, issn 0340-7004, 1511-1571 [64 p.]Conference Paper

Targeting HER2: Recent developments and future directions for breast cancer patientsHORTOBAGYI, Gabriel N.Seminars in oncology. 2001, Vol 28, Num 6, issn 0093-7754, 61 p., SUP18Conference Proceedings

Overview of treatment results with trastuzumab (herceptin) in metastatic breast cancerHORTOBAGYI, Gabriel N.Seminars in oncology. 2001, Vol 28, Num 6, pp 43-47, issn 0093-7754, SUP18Conference Paper

Cisplatin resistance is associated with reduced interferon-γ-sensitivity and increased HER-2 expression in cultured ovarian carcinoma cellsMARTH, C; WIDSCHWENDTER, M; KAERN, J et al.British journal of cancer. 1997, Vol 76, Num 10, pp 1328-1332, issn 0007-0920Article

HER3, p95HER2, and HER2 protein expression levels define multiple subtypes of HER2-positive metastatic breast cancerLIPTON, Allan; GOODMAN, Laurie; NEWTON, Alicia et al.Breast cancer research and treatment. 2013, Vol 141, Num 1, pp 43-53, issn 0167-6806, 11 p.Article

A CpG oligodeoxynucleotide potentiates the anti-tumor effect of HSP65-Her2 fusion protein against Her2 positive B16 melanoma in miceYOUYOU YAN; ZHAO CAO; MING YANG et al.International immunopharmacology (Print). 2012, Vol 12, Num 2, pp 402-407, issn 1567-5769, 6 p.Article

Akt expression and compartmentalization in prediction of clinical outcome in HER2-positive metastatic breast cancer patients treated with trastuzumabGRELL, Peter; FABIAN, Pavel; KHOYLOU, Marta et al.International journal of oncology. 2012, Vol 41, Num 4, pp 1204-1212, issn 1019-6439, 9 p.Article

In situ detection of HER2:HER2 and HER2:HER3 protein― protein interactions demonstrates prognostic significance in early breast cancerSPEARS, Melanie; TAYLOR, Karen J; MUNRO, Alison F et al.Breast cancer research and treatment. 2012, Vol 132, Num 2, pp 463-470, issn 0167-6806, 8 p.Article

Relationship between pathological features, HER2 protein expression and HER2 and CEP17 copy number in breast cancer: biological and methodological considerationsLAMBEIN, Kathleen; PRAET, Marleen; FORSYTH, Ramses et al.Journal of clinical pathology. 2011, Vol 64, Num 3, pp 200-207, issn 0021-9746, 8 p.Article

A study of HER2 gene amplification and protein expression in gastric cancerYAN, Benedict; EE XUAN YAU; SITI SHYBA BTE OMAR et al.Journal of clinical pathology. 2010, Vol 63, Num 9, pp 839-842, issn 0021-9746, 4 p.Article

Serum levels of shed Her2/neu protein in men with prostate cancer correlate with disease progressionOSMAN, Iman; MIKHAIL, Maryann; SHUCH, Brian et al.The Journal of urology. 2005, Vol 174, Num 6, pp 2174-2177, issn 0022-5347, 4 p.Article

Inhibitors of HER2/neu (erbB-2) signal transductionARTEAGA, Carlos L; CHINRATANALAB, Wichai; CARTER, Mary Beth et al.Seminars in oncology. 2001, Vol 28, Num 6, pp 30-35, issn 0093-7754, SUP18Conference Paper

Human epidermal growth factor receptor 2 (HER2) immunoreactivity: specificity of three pharmacodiagnostic antibodiesSCHROHL, Anne-Sofie; CHRISTIAN PEDERSEN, Hans; STEEN JENSEN, Sussie et al.Histopathology. 2011, Vol 59, Num 5, pp 975-983, issn 0309-0167, 9 p.Article

Protein array technology to detect HER2 (erbB-2)-induced 'cytokine signature' in breast cancerVAZQUEZ-MARTIN, Alejandro; COLOMER, Ramon; MENENDEZ, Javier A et al.European journal of cancer (1990). 2007, Vol 43, Num 7, pp 1117-1124, issn 0959-8049, 8 p.Article

  • Page / 3